AzTrials
AzTrials

Postpartum HemorrhageNCT07854106

Hybrid Simulation in Postpartum Hemorrhage Training for Nursing Students

A study testing Hybrid Simulation-Based PPH Training and Standard Education in people with Postpartum Hemorrhage and Simulation Training, run by Uludag University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Abstract Postpartum hemorrhage (PPH) is a leading cause of maternal mortality and morbidity worldwide, requiring nursing students to acquire both theoretical knowledge and clinical competence for safe and effective management. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Hybrid Simulation-Based PPH Training and Standard Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
23 Feb 2026to 29 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Being an undergraduate nursing student at Eskisehir Osmangazi University Faculty of Health Sciences
  • Being a third-year student enrolled in the Women's Health and Diseases Nursing course for the first time
  • Volunteering to participate and providing written informed consent
  • Not having previously received structured simulation training on postpartum hemorrhage management
  • Having no physical, cognitive, or psychiatric health conditions that impair communication

Who cannot join

  • Incomplete completion of data collection instruments
  • Non-attendance at pre-test or post-test assessments
  • Failure to complete the assigned educational intervention
  • Withdrawal of consent or voluntary withdrawal at any stage of the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Eskisehir Osmangazi University Faculty of Health Sciences

    Eskişehir, Eyalet/İl Seçin

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Hybrid Simulation-Based Postpartum Hemorrhage Management Training on Nursing Students' Satisfaction, Self-Confidence, and Clinical Readiness in Women's Health Nursing Education: A Randomized Controlled Trial

Abstract Postpartum hemorrhage (PPH) is a leading cause of maternal mortality and morbidity worldwide, requiring nursing students to acquire both theoretical knowledge and clinical competence for safe and effective management. Hybrid simulation, integrating standardized patients with high-fidelity simulators, is an innovative educational approach that simultaneously enhances communication and psychomotor skills.

This prospective randomized controlled study aims to evaluate the effects of a hybrid simulation-based postpartum hemorrhage management training on nursing students' learning satisfaction, self-confidence, and clinical readiness.

Read more

The study was conducted with third-year nursing students at Eskisehir Osmangazi University Faculty of Health Sciences, Department of Nursing. Participants were randomly assigned to either an intervention group receiving hybrid simulation-based training using standardized patients and a birthing simulator, or a control group receiving routine education.

Data were collected before and after the intervention using a Personal Information Form, the Student Satisfaction and Self-Confidence in Learning Scale, and the Nursing Clinical Readiness Scale to evaluate outcomes between the groups.

Being tested
Hybrid Simulation-Based PPH Training, Standard Education
Keywords
Postpartum Hemorrhage, Clinical Readiness, Simulation Training, Nursing education, learning satisfaction and self-confidence
Medical subject headings
Postpartum Hemorrhage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hybrid Simulation-Based PPH TrainingBehavioural

    Students receive interactive hybrid simulation-based training combining standardized patients and task trainers focused on postpartum hemorrhage management skills, clinical decision-making, and team communication.

  • Standard EducationBehavioural

    Students receive traditional curriculum-based theoretical education and standard lecture-based instruction on postpartum hemorrhage management.

Study groups in NCT07854106
Study groupRoleWhat they receive
Intervention GroupExperimentalNursing students receiving hybrid simulation-based postpartum hemorrhage (PPH) management training.
Receives: Behavioral: Hybrid Simulation-Based PPH Training
Control GroupActive comparatorNursing students receiving standard postpartum hemorrhage management education.
Receives: Behavioral: Standard Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Readiness for Nursing Practice Scale

    Assessed using the Turkish version of the Nursing Clinical Readiness Scale (originally developed by Kim and Shin, 2022; Turkish validation by Kavuran et al., 2023) to evaluate nursing students' clinical readiness in managing postpartum hemorrhage. The scale consists of 35 items rated on a 10-point Likert scale ranging from 1 (strongly disagree) to 10 (strongly agree). Total scores range from 35 to 350 (or mean item scores from 1 to 10), where higher scores indicate a higher level of clinical readiness.

    Measured: Baseline and immediately post-intervention

  2. Student Satisfaction and Self-Confidence in Learning Scale

    Assessed using the Turkish version of the Student Satisfaction and Self-Confidence in Learning Scale (originally developed by Jeffries and Rizzolo, 2006; Turkish validation by Unver et al., 2017). The scale consists of 12 items across two subscales: Satisfaction with Current Learning (5 items) and Self-Confidence in Learning (7 items), rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Scores are calculated by dividing the sum of scores by the number of items, with mean scores ranging from 1 to 5 (total score range: 12 to 60), where higher scores indicate higher levels of student satisfaction and self-confidence in learning.

    Measured: Baseline and immediately post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Oct 2026
  2. Study start23 Feb 2026
  3. Primary completion24 Mar 2026
  4. Study completion29 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07854106
Sponsor's protocol ID
UludagU-SHMYO-MU-02
Other IDs
2025-SBB-1124
Status last verified
Oct 2026
First submitted
25 Sep 2026
Last updated
2 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared publicly to protect participant confidentiality. De-identified data may be made available from the corresponding author upon reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing Hybrid Simulation-Based PPH Training and Standard Education in people with Postpartum Hemorrhage and Simulation Training, run by Uludag University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Readiness for Nursing Practice Scale (time frame: Baseline and immediately post-intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07854106 | AzTrials